Loading paragraph...
Today's Biggest Stock Gainers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| OTCRX | Otter Creek Long/Short Opportunity Fund - Investor Class | $14.41 | $11.93 | 480.50% | - | - | - |
| PRAX | Praxis Precision Medicines | $168.53 | $111.18 | 1.94% | 12.4M | $1.2B | $26.7$205.89 |
| RYOJ | rYojbaba | $3.83 | $1.66 | 0.76% | 24.6M | $24.4M | $1.81$5.35 |
| APLM | Apollomics | $30.54 | $11.04 | 0.57% | 242K | $21.5M | $3.66$42.12 |
| LGCB | Linkage Global | $2.2 | $0.55 | 0.33% | 50.8M | $22.4M | $1.22$6.83 |
| ELWS | Earlyworks | $5.42 | $1.74 | 0.47% | 30.5M | $11.1M | $1.64$10.5 |
| SNSE | Sensei Biotherapeutics | $17.7 | $4.03 | 0.29% | 95.6K | $17.2M | $5$18.35 |
| RGTZ | Tidal Trust II - Defiance Daily Target 2x Short Rgti ETF | $11 | $2.3 | 0.26% | 44.4M | - | $8.14$20.39 |
| WHWK | Whitehawk Therapeutics Inc | $2.63 | $0.53 | 25.00% | - | - | - |
| LITB | LightInTheBox | $2.48 | $0.49 | 0.25% | 46.1K | $36.6M | $0.91$2.51 |
Related Articles
Featured Article
This Cancer Detection Pioneer Is Worth a Look
Matthew Benjamin|Sep 26, 2025
Multicancer detection tests are closing in on FDA approval and potentially major sales.
3 Top Takeaways from J.B. Hunt's Outstanding Q3
Rhian Hunt|Oct 28, 2021
The company's big rigs are hauling in profits, though lack of truckers casts a shadow on its potential gains.
Cathie Wood Goes Dumpster Diving: 3 Beaten Down Stocks She Just Bought
Cory Renauer|Sep 9, 2021
All of these stocks are more than 40% below their peaks, but at least one important investor thinks they can recover.
This Penny Stock Is Built on Hype and Broken Promises
Leo Sun|Apr 30, 2021
Energous is trading at nearly half its IPO price for obvious reasons.
Sell-Off? Correction? These 3 Stocks Are Already 40% Off Their Highs
Rick Munarriz|Mar 23, 2021
In a little more than a month, these three stocks have surrendered between 42% and 47% of their value. This correction could use a correction.
If You Invested $10,000 in Personalis in the Coronavirus Crash, This Is How Much You'd Have Now
Taylor Carmichael|Jan 23, 2021
Investors weren't very happy when shares tanked in March, but have been smiling ever since.
3 Stocks Under $10 That Have Already Doubled in 2020
Rick Munarriz|Sep 3, 2020
A producer of animated kids shows, a food delivery tech specialist, and a Chinese internet retailer have all more than doubled this year. They all still trade in the single digits.
3 Stocks Under $3 That Should Bounce Back in 2021
Rick Munarriz|Aug 25, 2020
A senior community specialist, online travel portal, and Chinese e-commerce speedster all trade for less than a Happy Meal. The catalysts are there for a heartier meal.
Personalis Turns to Liquid Biopsies for Growth. Will It Work?
Maxx Chatsko|Aug 14, 2020
The company, which leans on one customer for 76% of revenue, desperately needs to diversify its customer base.
NextCure Delays 2 Clinical Trials Due to Coronavirus
Eric Volkman|Apr 14, 2020
The company cited patient safety concerns and the current strains on hospitals as the reasons for the postponements.
